Skip to main content

Table 2 HIV Positive Participants Clinical Characteristics

From: Neurocognitive impairment in treatment-experienced adults living with HIV attending primary care clinics in Zimbabwe

Characteristic

Median (IQR)

aCD4 count (cells/mm3)

520 (300–699)

Nadir CD4 count (cells/mm3)

250 (135–430)

Time since HIV Diagnosis (Months)

73 (30–113)

Time since ART Initiation (Months)

69 (29–107)

bAdherence Self Report Score

24.5 (21–25)

Current ART Regimen

Frequency

First Line ART regimen

 Stavudine/Lamivudine/Nevirapine

2%

 Tenofovir/Lamivudine/Nevirapine

2%

 Zidovudine/Lamivudine/Nevirapine

1%

 Tenofovir/Lamivudine/Efavirenz

93%

Second Line ART regimen

 Abacavir/Lamivudine/Atazanavir

2%

Medication Switched Since Initiation

 Yes

30%

 No

70%

  1. Note: aMost recent CD4 count as per clinic records. bScored out of 25